| Category | Key details | Key citations |
|---|---|---|
| identity | **Verified target**: zebrafish **gtpbp3** encodes mitochondrial **GTP-binding protein 3 / tRNA taurine modification enzyme GTPBP3**, a conserved **TrmE-type GTPase** with a mitochondrial targeting sequence and a TrmE-like G domain; this matches UniProt Q501Z5 and supports annotation as the zebrafish ortholog of mammalian mitochondrial GTPBP3 rather than another similarly named GTP-binding protein. Zhang et al. 2023 (*Genes*, Feb 2023) DOI/URL: https://doi.org/10.3390/genes14030552. | (pqac-00000001, pqac-00000003) |
| molecular function/reaction | **Primary function**: mitochondrial tRNA wobble-uridine modification. Cross-species evidence indicates GTPBP3 acts with MTO1 to catalyze formation of **τm5U / τm5(s2)U** at position **U34** of selected mitochondrial tRNAs, thereby supporting accurate mitochondrial translation. GTP hydrolysis by the TrmE-type G domain is functionally important for this reaction. Zhang et al. 2023 (*Genes*, Feb 2023) https://doi.org/10.3390/genes14030552; Magistrati et al. 2023 (*Int J Mol Sci*, Jan 2023) https://doi.org/10.3390/ijms24032178. | (pqac-00000003, pqac-00000004) |
| substrates/cofactors | Reported reaction inputs for the **GTPBP3–MTO1** system include **taurine** and **5,10-methylene-THF (5,10-CH2-THF)** as substrates, with **GTP, K+, and FAD** as required cofactors; under taurine starvation, the complex may use **glycine** to generate **cmnm5U** instead of τm5U. Upstream one-carbon units are supplied by **SHMT2** or the glycine-cleavage pathway. Zhang et al. 2023 https://doi.org/10.3390/genes14030552; Magistrati et al. 2023 https://doi.org/10.3390/ijms24032178. | (pqac-00000003, pqac-00000004) |
| partners/complex | GTPBP3 forms a functional complex with **MTO1**; Zhang et al. describe a heterologous tetrameric complex in which the GTPBP3 N-terminus mediates dimerization and the central helix contacts MTO1. Related taurine-dependent mt-tRNA modification pathways also involve **TRMU/MTU1** for 2-thiolation downstream/parallel to τm5U biogenesis. Zhang et al. 2023 https://doi.org/10.3390/genes14030552; Magistrati et al. 2023 https://doi.org/10.3390/ijms24032178. | (pqac-00000003, pqac-00000004) |
| localization | **Subcellular localization**: mitochondrion. Evidence includes annotation as a **mitochondrial tRNA-modifying enzyme**, presence of a mitochondrial targeting signal, and disease/mechanistic literature consistently placing GTPBP3 in the mitochondrial tRNA modification machinery. 2024 Chinese review URL: https://doi.org/10.12125/j.chj.202212029; Zhang et al. 2023 https://doi.org/10.3390/genes14030552. | (pqac-00000000, pqac-00000001, pqac-00000003) |
| zebrafish LOF phenotype | **Danio rerio loss-of-function evidence is limited but consistent**: cited zebrafish studies report that deletion/defective expression of **gtpbp3** causes **hypertrophic cardiomyopathy** with **aberrant mitochondrial tRNA metabolism**, altered mitochondrial function, and developmental defects. Secondary cross-reference from zebrafish Mto1 work notes similar mt-tRNA instability signatures and reports **increased tRNA aminoacylation efficiencies** in **gtpbp3KO** zebrafish. Detailed direct zebrafish biochemical readouts are sparsely available in the retrieved texts, so mechanistic annotation relies partly on orthology and the MTO1/GTPBP3 pathway. | (pqac-00000008, pqac-00000009, pqac-00000010) |
| human disease links/2023-2024 stats | **Human ortholog evidence strongly supports function**. Biallelic **GTPBP3** variants cause **COXPD23** with lactic acidosis/hyperlactatemia, hypertrophic cardiomyopathy, seizures, developmental delay, and encephalopathy. **Zhang et al. 2023** curated **18 patients**, average onset **1.7 years** (reported **3 months** for a homozygote); patient variants showed **48.6% LOF** vs **8.9%** in gnomAD (**p < 0.0001**), **31% frameshift**, and severe cases were **71.4% homozygous** vs **18.1% compound heterozygous**. **Xie et al. 2024** identified **13 variants in 9 Chinese pedigrees**, including **8 novel** variants; features included developmental delay, seizures, hypotonia, exercise intolerance, hypertrophic cardiomyopathy, plus newly noted **strabismus** and **heart valve** findings; example quantitative values included lactate **16 mM** and **8.58 mM**, EF **38%**, NT-proBNP **894 pg/ml**. The 2024 Chinese review also cites a pediatric case presenting at **3 y 5 m** with **LVEF 27%** and lactate **3.2 mmol/L**. URLs: Zhang 2023 https://doi.org/10.3390/genes14030552; Xie 2024 https://doi.org/10.1186/s13023-024-03469-3; Chinese review 2024 https://doi.org/10.12125/j.chj.202212029. | (pqac-00000003, pqac-00000005, pqac-00000007, pqac-00000000) |


*Table: This table summarizes the key functional annotation points for zebrafish gtpbp3 (UniProt Q501Z5), separating direct zebrafish evidence from cross-species inference. It is useful for identifying what is strongly supported experimentally versus what is inferred from the conserved mitochondrial GTPBP3-MTO1 tRNA modification pathway.*